Gilead, LEO Pharma partner to develop programs for inflammatory diseases By Reuters
(Reuters) - Gilead Sciences (NASDAQ:) said on Saturday that it entered into a partnership with Denmark's LEO Pharma to develop...
programs
23andMe cuts 40% of its workforce, discontinues all therapy programs By Reuters
(Reuters) -Genetic testing firm 23andMe said on Monday it is reducing about 40%, or 200 employees, from its workforce and...
Harris County, Texas commissioner slams guaranteed income programs: ‘They don’t change anything’
Join Fox News for access to this content Plus special access to select articles and other premium content with your...
